The activation of the TLR4/NF-κB signaling pathway could modulate NLRP3 inflammasome activation in inflammatory bowel disease and induce GSDMD-mediated pyroptosis in tubular cells in diabetic kidney disease (Chen et al., 2019; Wang Y. et al., 2019). Here, NLRP3 is linked to inflammatory bowel disease.